abstract |
The invention discloses a class of novel apigenin derivatives, pharmaceutical compositions containing the compounds and their anti-renal cancer applications. It is a compound represented by formula (I) or a stereoisomer, geometric isomer, tautomer, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically an acceptable salt or a prodrug thereof, |